Nursing Elites

1. A nurse is providing teaching to a client who has a new prescription for ferrous sulfate. Which of the following instructions should the nurse include?

• A. Take this medication with orange juice to increase absorption.
• B. Take this medication on an empty stomach.
• C. Take this medication with milk if it causes stomach upset.
• D. Take this medication at bedtime.

Correct answer: A

Rationale: The correct instruction for a client prescribed ferrous sulfate is to take the medication with orange juice to enhance absorption. Orange juice is recommended because of its vitamin C content, which aids in the absorption of iron. Choice B, taking the medication on an empty stomach, is incorrect because ferrous sulfate is better absorbed with food. Choice C, taking the medication with milk if it causes stomach upset, is incorrect as calcium in milk can interfere with iron absorption. Choice D, taking the medication at bedtime, is incorrect as it is usually recommended to take iron supplements between meals or with food to enhance absorption.

2. A nurse is assessing a school-age child with a urinary tract infection. What symptom should the nurse expect?

• A. Periorbital edema.
• B. Decreased frequency of urination.
• C. Enuresis.
• D. Diarrhea.

Correct answer: C

Rationale: The correct answer is C: Enuresis. Enuresis, which refers to involuntary urination, is a common symptom of urinary tract infections in children. Periorbital edema (choice A) is more commonly associated with conditions like nephrotic syndrome. Decreased frequency of urination (choice B) is not typically seen in urinary tract infections, as these infections often present with increased frequency. Diarrhea (choice D) is not a typical symptom of a urinary tract infection.

3. A healthcare provider is reviewing the medical record of a client who is requesting combination oral contraceptives. Which of the following conditions in the client's history is a contraindication to the use of oral contraceptives?

• A. Hyperthyroidism.
• B. Thrombophlebitis.
• C. Diverticulosis.
• D. Hypocalcemia.

Correct answer: B

Rationale: Thrombophlebitis is a contraindication for the use of oral contraceptives due to the increased risk of complications such as thromboembolism. Hyperthyroidism, diverticulosis, and hypocalcemia are not contraindications for oral contraceptives. Hyperthyroidism may affect the metabolism of contraceptives but does not contraindicate their use. Diverticulosis and hypocalcemia do not directly impact the safety or effectiveness of oral contraceptives.

4. Which lab value should be monitored in patients receiving furosemide?

• A. Monitor potassium levels
• B. Monitor sodium levels
• C. Monitor calcium levels
• D. Monitor glucose levels

Correct answer: A

Rationale: The correct answer is to monitor potassium levels in patients receiving furosemide. Furosemide is a loop diuretic that can lead to potassium loss in the urine, potentially causing hypokalemia. Monitoring potassium levels is crucial to prevent complications associated with low potassium levels, such as cardiac arrhythmias. Monitoring sodium levels (choice B) is not typically necessary with furosemide use, as it primarily affects potassium levels. Calcium levels (choice C) and glucose levels (choice D) are not directly impacted by furosemide and require monitoring for other conditions or medications.

5. A nurse is assisting with the development of an informed document for participation in a research study. Which of the following information should the nurse include?

• A. A statement that participants can leave the study at will.
• B. An assignment of the participant to either the experimental or control group.
• C. A list of the clients participating in the study.
• D. A description of the framework the researchers will use to evaluate the data.

Correct answer: A

Rationale: The correct answer is A: 'A statement that participants can leave the study at will.' This information is crucial to include in the informed document to ensure that participants are aware of their right to withdraw from the study at any time without any negative consequences. Choice B is incorrect because participants should not be assigned to experimental or control groups without their knowledge and consent. Choice C is incorrect because disclosing a list of clients participating in the study violates confidentiality. Choice D is incorrect as the description of the data evaluation framework is important but not as critical as ensuring participants know they can leave the study at will.

Similar Questions